Atlanta Endocrine Associates

12/04/2023

All patients with type 2 diabetes should be screened for NAFLD/MASLD. https://www.medscape.com/viewarticle/993715

10/01/2023

Our paper on the identification of high-risk patients with NAFLD/MASLD in endocrinology clinics. Free download via this author link.
https://authors.elsevier.com/c/1hrTF_,3UnYHv6r

04/28/2023

Dr. Isaacs was interviewed for this story for CBS Evening News about

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be s...

01/31/2023

Diabetes medications that promote weight loss improve NAFLD. But, it remains unclear if glycemic control itself is beneficial for NAFLD.
https://www.healio.com/news/endocrinology/20230118/meeting-target-hba1c-may-improve-nafld-for-adults-with-type-2-diabetes

01/18/2023

Reproductive aged women have lower rates of NAFLD compared with men; however, NAFLD prevalence in postmenopausal women is similar to or exceeds that in men. https://www.healio.com/news/womens-health-ob-gyn/20230109/odds-of-nonalcoholic-fatty-liver-disease-greater-after-menopause

01/18/2023

The ability of and to melt weight away by tweaking biology gives credence to the idea that obesity is a disease. https://www.nature.com/articles/d41586-022-04505-7

01/16/2023

Weight regain is expected if a weight loss medication is discontinued. My comments about Remi Bader's use and discontinuation of for Insider.

An endocrinologist told Insider that semaglutide is meant for long-term use because it treats chronic conditions like obesity and diabetes.

01/13/2023

Recommendations to enable and optimize a multidisciplinary approach in NAFLD care.

: Recommendations to enable and optimize a multidisciplinary approach in care. nature.com/articles/s4385… Evaluate benefit and cost-effective...…

01/06/2023

It was such an honor to be part of the first annual Canadian NAFLD & NASH Summit. Here is a recording of my presentation about the relationship between NAFLD/NASH and Type 2 Diabetes, obesity, cardiovascular risk.

NAFLD/NASH and the relationship to Type-2 Diabetes, Obesity & Cardiovascular Risk with Dr. Scott Isaacs, Endocrinologist.

12/13/2022

Dr. Isaacs' new article on testing for fatty liver disease.

A practical use of non-invasive tests in clinical practice to identify and stratify high-risk patients with non-alcoholic steatohepatitis.

12/12/2022

Twittorial about the link between fatty liver and heart disease. https://threadreaderapp.com/thread/1601962266315874311.html

11/18/2022

Reversing fatty liver disease is a key factor in diabetes remission.

Endocrinology and Metabolism Clinics of North AmericaAvailable online 18 November 2022In Press, Corrected ProofWhat are Corrected Proof articles?Nonalcoholic Fatty Liver DiseaseAuthor links open overlay panelScottIsaacsMDabShow moreShareCitehttps://doi.org/10.1016/j.ecl.2022.06.007Get rights and con...